View all IQVIA events
-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Life Sciences
-
Healthcare
Life Sciences
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreLife Sciences
Healthcare
Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreHealthcare
U.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREBLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS
PODCASTS
"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTSRequirements for medical devices are evolving, making evidence-based decisions more relevant than ever, especially when it comes to proving safety, effectiveness, improved patient outcomes, and regulatory requirements. In addition, there is an increasing need to accomplish this more rapidly and with greater cost-effectiveness. This is where real world data (RWD) and linked data sources come into play. Some of the most pressing challenges include understanding patient profiles, treatment patterns, healthcare burden, and clinical outcomes in the real world environment.
Key Learning Objectives:
- Understand how RWE strategies can be used to support development needs in the medical technology arena, including research initiatives, market development, and reimbursement planning, using comparative effectiveness analyses.
- Review how rich data sources used in real world evidence studies (e.g., claims data, laboratory data, EMRs, etc.) can be used to support clinical evidence requirements.
- Explore how RWE studies can support regulatory affairs strategies to satisfy market approval requirements.
- Learn how linked/integrated data sources provide options to support evidence development requirements.
- Understand what is needed for success as it relates to the evolving MedTech regulatory landscape and how RWE is being used for regulatory decision-making.
Speakers
Mitch DeKoven, MHSA
Senior Principal, Health Economics and Outcomes Research, Real World Solutions, IQVIA
Michael Hull, MS
Associate Principal, Health Economics and Outcomes Research, Real World Solutions, IQVIA
Brinda Sriskantha, PhD
Global Portfolio Strategy Lead, Real World Evidence MedTech, IQVIA